Overview

Preventive Treatment of Episodic and Chronic Migraine

Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is an open label pilot study to determine whether milnacipran can reduce headache frequency in episodic and chronic migraine sufferers.
Phase:
Phase 4
Details
Lead Sponsor:
California Medical Clinic for Headache
Treatments:
Levomilnacipran
Milnacipran